Although generally well tolerated, statins, compared with placebo, have been associated with a higher incidence of new-onset diabetes mellitus (DM) in several experimental studies and a meta-analysis of 13 randomized controlled trials (RCTs).1,2
Although generally well tolerated, statins, compared with placebo, have been associated with a higher incidence of new-onset diabetes mellitus (DM) in several experimental studies and a meta-analysis of 13 randomized controlled trials (RCTs).1,2